Similarly, MYC is overexpressed in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) and is able to inhibit the expression of the circadian clock gene Period2 (Per2), which is highly expressed in neutrophils where it enhances antitumor proliferation [72]. This evidence concerns the gene PER2 and acute myeloid leukemia.